Evidence map›Paper›PMID 42192735›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Unraveling Cefiderocol Resistance in NDM- and OXA-48-like Co-Producing

Simone Ambretti, Raul Cetatean, Benedetta Secci, Jessica Landi, Alessia Cantiani, Claudio Foschi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simone AmbrettiMicrobiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0002-8358-339X
Raul CetateanDepartment of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
Benedetta SecciMicrobiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Jessica LandiDepartment of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Alessia CantianiDepartment of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0009-0007-0405-2739
Claudio FoschiMicrobiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0001-7253-8799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThe co-production of New Delhi metallo-β-lactamases (NDM) and OXA-48-like carbapenemases in

methodsA total of 45 clinical

resultsMost isolates belonged to the high-risk clone ST147 (44/45) and were grouped into three main phylogenetic clusters. The isolates exhibited extensive multidrug resistance, with universal susceptibility only for aztreonam/avibactam. Cefiderocol resistance was observed in 42.2% of isolates and was unevenly distributed across the phylogeny. Mutations in iron uptake genes, particularly

conclusionsNDM- and OXA-48-like carbapenemase co-producing

Indexed as

aztreonam/avibactamcarbapenemasecefiderocolKlebsiella pneumoniaeNDMOXA-48WGS

Identifiers

PMID42192735
PMCPMC13203471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.